cancer antigen (BASCA) in developing lung and in lung tumors was investigated immunohistochemically and immunoelectron miaoscopically with monodonal antibodies recognizing different epitopes of BASCA.
In fetal lung, epithelial and mesenchymal cells had different spatial and temporal expression l tterns, in contrast to the consistent ttem in neural cells The cell membranes ofepitheial cells ofthe proximal bronchial tubes were diffusely positive at the pseudoglandular stage.
Ciliated cells lost immunoreactivity shortly after their emergence, but non-ciliated cells, induding endocrine cells, lost it at the alveolar stage. The immunoreactivity in mesenchymal cells was reduced in the proximal airway,
Introduction
Monoclonal antibodies (MAb) were raised against small-cell carcinoma of the lung (SCCL) for investigation of this particular type oflung cancer (14) . Interestingly, many of the MAb also react with normal and neoplastic neural tissues, and the majority of them (4, 11, 12, 15) recognize a common antigen, brain-associated smallcell cancer antigen (BASCA), which was recently purified from human brain (16) . BASCA is a 124 KD cell surface antigen, probably containing three different epitopes (18). However, there have been several questions about the significance of BASCA in SCCL. As no unequivocal evidence has been obtained for the presence of BASCA in the lung tissue, the question is whether or not BASCA is tumor sp&ific in the lung. BASCA expression could be observed in some non-SCCL (2, 12, 17) , but this fact has been interpreted as neuroendocnine differentiation in non-SCCL (2). This view appears but positivity remained in the distal lung later during the postnatal period.
All endocrine tumors ofthe lung, defmed by diffuse synaptophysin immunoreactivity, expreased BASCA, but some non-endoaine carcinomas which also laCked densely cored granules ultrastructurally, showed BASCA positivity. The temporal and spatial pattern of BASCA expression in the developing lung suggests that BASCA plays an active role inlung morphogenesis. BASCA may be expressed as an oncofetal substance in some non-endocrine carcinomas of the lung. 38:51-57, 1990) KEY WORDS: These MAb recognize at least two and possibly three different epitopes (18). All four MAb react with purified BASCA, but TFS6, which was obtained using BASCA as immunogen, did not immunolabel the viable SCCL cells, suggesting that the epitope recognized by TFS6 is not present at the outer side of the membrane.
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In contrast, the other three MAb reacted with viable cells, but 6H7 showed no interaction with TFS4 or MOC1 in competitive inhibition assay of BASCA. Therefore, BASCA has at least two (6H7 and TFS4/MOC1), and possibly a third (TFS6), epitopes. The MAb for synaptophysin (SY38)was purchased from Boehninger (Mannheim, FRG). The cryostat sections were immunostained with MAb in optimal dilution; 1 ng/ml for l'FS4, 10 ng/ml for TFS6, iSo for cornmercially available MOC1, 1 pg/mlfor6H7, and 3 tg/ml for synaptophysin.
Immunoelectron
Microscopy (IEM). The pre-embedding method for LEM was applied to representative cases: fetal lungs (n = 7), adult lungs with fibrosis (n = 2), SCCLS (n = 4), carcinoids (n = 2), atypical endocnine rumor (n = 1), squamous cell carcinomas (n -4), and adenocarcinomas (n 1). Ten-micrometer sections adjacent to those for light microscopy were immunostained with MAb for BASCA as described above. The sections were reacted overnight with Fab fragments of rabbit anti-mouse immunoglobulin conjugated with horseradish percacidase. The sections were post-fixed with 1.0% glutaraldehyde in PBS for 15 mm, washed, and preincubated with 0.02% 3,3'-diaminobenzidine, 10 mM sodium azide, and 1% dimethylsulfoxide in 0.05 M Tris buffer, pH 7.6, for 30 mm. Then the peroxidase reaction was developed by adding 0.005% H2O2 for 5 mm. The sections were post-fixed with 1.0% osmium tetroxide for 1 hr at room ternperature, dehydrated in ethanol, and embedded in Epon 812. Ultra-thin sections were viewed with a Hitachi H-7000 electron microscope.
For ideatification of cell types in detail, adjacent ultra-thin sections were doubly stained with uranyl acetate and lead citrate.
ControlStudies
Controlstudies
induded the replacement of MAb with non-immune mouse immunoglobulin and omission of the MAb, applied to all cases for light microscopy and to selected cases (frtal lungs, carcinoid tumors, and two non-SCCL) for electron microscopy. 
Results
In all tissues studied, four MAb showed similar reaction patterns, Figure  1B) . At the canalicular stage (gestational week 19-23) when bronchial branching has been completed, the number of immunoreactive cells drastically decreased in the bronchial tree ( Figure  1C ). Figure  3A) , but the immunoreaction for BASCA soon disappeared at the lateral surface membrane of ciliated cells ( Figure  3B ). Non-ciliated cells continued to express BASCA at the canalicular stage, when the immunoreactivity appeared to be discontinuous at the points of membrane contact. These non-ciliated cells were endocrine cells with dense-cored granules ( Figure  3C ), basal cells with prominent tonofilaments ( Figure  3D ), and cells without definite differentiation. Among these non-ciliated cells, endocrine cells appeared to be the dominant cell type at the canaliculan stage ( Figure  3G ).
BASCA-expressing mesenchymal cells ( Figure  3E ) surrounded the developing bronchial structure, especially its distal portion. Some positive cells surrounding the bronchi had bundles of actin filaments, indicating that they were smooth muscle cells ( Figure   3F 
BASCA in Fibrosed Lung
In one of two specimens of fibrosed lung tissue ( Figure  4A ), some epithelial cells in bronchiolized structures showed positivity with MAb for BASCA. Positivity was seen at the lateral membranes of some non-ciliated and non-endocrine cells ( Figure  4B ). Endocrine cells with dense-cored granules did not show BASCA expression in both samples of fibrosed lung.
BASCA in Lung Tumors
Consistent with previous studies, all ofthe endocrine tumors showed diffuse staining reaction for BASCA at the cell membrane and for synaptophysin in the cytoplasm. However, in non-endocrine carci- 
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